Kidney Transplant Research Today is a free monthly online journal that collates and summarizes the latest research about Kidney Transplant, including details on risks, prognosis, procedure, surgery, organ donation.

Volume 4 (2007), Issue 4 (April)

1. Echocardiography-based score to predict outcome after renal transplantation.
   Heart, 93(4): 464-9. [Abstract] [Full-text]
2. Jon Van Rood: pioneer at the crossroad of human leukocyte antigens and transplantation.
   Transfus Med Rev, 21(2): 159-63. [Abstract] [Full-text]
3. The alloantigenic sites of alpha3alpha4alpha5(IV) collagen: pathogenic X-linked alport alloantibodies target two accessible conformational epitopes in the alpha5NC1 domain.
   J Biol Chem, 282(14): 10670-7. [Abstract] [Full-text]
4. Detection of early renal transplant rejection by minimally-invasive monitoring of impedance variability.
   Biosens Bioelectron, 22(11): 2749-53. [Abstract] [Full-text]
5. Comparison of fluorescent polarization immunoassay (FPIA) versus HPLC to measure everolimus blood concentrations in clinical transplantation.
   Clin Chim Acta, 380(1): 217-21. [Abstract] [Full-text]
6. The implementation of a kidney exchange program does not induce a need for additional psychosocial support.
   Transpl Int, 20(5): 432-9. [Abstract] [Full-text]
7. An outbreak of Pneumocystis jiroveci pneumonia with 1 predominant genotype among renal transplant recipients: interhuman transmission or a common environmental source?
   Clin Infect Dis, 44(9): 1143-9. [Abstract] [Full-text]
8. Cholesterol embolization in renal allografts: a clinicopathologic study of 12 cases.
   Am J Surg Pathol, 31(4): 536-45. [Abstract] [Full-text]
9. Influence of the UGT2B7 promoter region and exon 2 polymorphisms and comedications on Acyl-MPAG production in vitro and in adult renal transplant patients.
   Pharmacogenet Genomics, 17(5): 321-30. [Abstract] [Full-text]
10. The use of psychosocial criteria in Australian patient selection guidelines for kidney transplantation.
    Soc Sci Med, 64(10): 2107-14. [Abstract] [Full-text]
11. Acute humoral rejection of renal transplants in alloimmunized pigs.
    J Surg Res, 139(2): 261-8. [Abstract] [Full-text]
12. Urinary tract infections and bladder dysfunction after renal transplantation in children.
    J Urol, 177(5): 1883-6. [Abstract] [Full-text]
13. Computerized tomographic angiography for renal donor evaluation leads to a higher exclusion rate.
    J Urol, 177(5): 1826-9. [Abstract] [Full-text]
14. Partial nephrectomy and autotransplantation with pyelovesicostomy for renal urothelial carcinoma in solitary kidneys: a clinical update.
    BJU Int, 99(5): 1020-3. [Abstract] [Full-text]
15. Fish oil for kidney transplant recipients.
    Cochrane Database Syst Rev. [Abstract] [Full-text]
16. Percutaneous radiofrequency ablation of tumor in transplanted kidney.
    Urology, 69(4): 778.e5-7. [Abstract] [Full-text]
17. Deceased-donor kidney transplantation in prune belly syndrome.
    Urology, 69(4): 666-9. [Abstract] [Full-text]
18. Necessity of routine postoperative heparinization in non-risky live-donor renal transplantation: results of a prospective randomized trial.
    Urology, 69(4): 647-51. [Abstract] [Full-text]
19. Chronic rejection: an enduring enigma of transplantation biology.
    Transplant Proc, 39(3): 773-8. [Abstract] [Full-text]
20. Polyclonal antibodies in renal transplantation--a relook.
    Transplant Proc, 39(3): 766-72. [Abstract] [Full-text]
21. Transplant arteriopathy.
    Transplant Proc, 39(3): 763-5. [Abstract] [Full-text]
22. Management of calculi in a donor kidney.
    Transplant Proc, 39(3): 761-2. [Abstract] [Full-text]
23. Monitoring of anti-HLA and anti-Major histocompatibility complex class I related chain A antibodies in living related renal donor transplantation.
    Transplant Proc, 39(3): 759-60. [Abstract] [Full-text]
24. Challenge of tuberculosis in renal transplantation.
    Transplant Proc, 39(3): 756-8. [Abstract] [Full-text]
25. Growth in pediatric renal transplant recipients.
    Transplant Proc, 39(3): 753-5. [Abstract] [Full-text]
26. Effect of bisphosphonates on bone mineral density after renal transplantation as assessed by bone mineral densitometry.
    Transplant Proc, 39(3): 750-2. [Abstract] [Full-text]
27. Tacrolimus (Pan Graf) in live related renal transplantation: an initial experience of 101 recipients in India.
    Transplant Proc, 39(3): 747-9. [Abstract] [Full-text]
28. Significance of anti-HLA and donor-specific antibodies in long-term renal graft survival.
    Transplant Proc, 39(3): 744-6. [Abstract] [Full-text]
29. Focal segmental glomerulosclerosis and renal transplantation.
    Transplant Proc, 39(3): 737-43. [Abstract] [Full-text]
30. Recurrent glomerulopathy in the renal allograft.
    Transplant Proc, 39(3): 734-6. [Abstract] [Full-text]
31. Opportunistic infections in renal allograft recipients.
    Transplant Proc, 39(3): 731-3. [Abstract] [Full-text]
32. Impact of retroperitoneoscopic donor nephrectomy on renal allograft in Indian and African recipients.
    Transplant Proc, 39(3): 723-5. [Abstract] [Full-text]
33. Cadaveric renal transplantation: our experience at the Institute of Kidney Diseases & Research Centre, Institute of Transplantation Sciences, Ahmedabad.
    Transplant Proc, 39(3): 721-2. [Abstract] [Full-text]
34. Transplant rejection under the microscope.
    Transplant Proc, 39(3): 662-6. [Abstract] [Full-text]
35. First case of simultaneous heart plus kidney transplantation in Chile: case report.
    Transplant Proc, 39(3): 625-6. [Abstract] [Full-text]
36. Converting to a generic formulation of mycophenolate mofetil in stable kidney transplant recipients: 1 year of drug surveillance and outcome.
    Transplant Proc, 39(3): 602-5. [Abstract] [Full-text]
37. Report of the experience with enteric-coated sodium mycophenolate in a de novo population of kidney transplant recipients at high risk for delayed graft function.
    Transplant Proc, 39(3): 600-1. [Abstract] [Full-text]
38. Therapeutic drug monitoring of mycophenolic acid in kidney transplant patients: a abbreviated sampling strategy.
    Transplant Proc, 39(3): 596-9. [Abstract] [Full-text]
39. Case report of a kidney transplant recipient converted to everolimus due to malignancy: resolution of bronchiolitis obliterans organizing pneumonia without everolimus discontinuation.
    Transplant Proc, 39(3): 594-5. [Abstract] [Full-text]
40. Conversion from a calcineurin inhibitor-based immunosuppressive regimen to everolimus in renal transplant recipients: effect on renal function and proteinuria.
    Transplant Proc, 39(3): 591-3. [Abstract] [Full-text]
41. 14th International HLA and Immunogenetics Workshop: report on the structural basis of HLA compatibility.
    Tissue Antigens, 69: 180-4. [Abstract] [Full-text]
42. 14th International HLA and Immunogenetics Workshop: report on the Prospective Chronic Rejection Project.
    Tissue Antigens, 69: 174-9. [Abstract] [Full-text]
43. Influence of rabeprazole and lansoprazole on the pharmacokinetics of tacrolimus in relation to CYP2C19, CYP3A5 and MDR1 polymorphisms in renal transplant recipients.
    Biopharm Drug Dispos, 28(4): 167-75. [Abstract] [Full-text]
44. Cold heparinized lactated Ringers with procaine (HeLP) preservation fluid in 266 living donor kidney transplantations.
    Transplantation, 83(8): 1134-6. [Abstract] [Full-text]
45. Renal transplantation in elderly patients older than 70 years of age: results from the Scientific Registry of Transplant Recipients.
    Transplantation, 83(8): 1069-74. [Abstract] [Full-text]
46. The functional, metabolic, and anabolic responses to exercise training in renal transplant and hemodialysis patients.
    Transplantation, 83(8): 1059-68. [Abstract] [Full-text]
47. No association of factor V Leiden, prothrombin G20210A, and MTHFR C677T gene polymorphisms with kidney allograft survival: a multicenter study.
    Transplantation, 83(8): 1055-8. [Abstract] [Full-text]
48. Gene-expression profiles and age of donor kidney biopsies obtained before transplantation distinguish medium term graft function.
    Transplantation, 83(8): 1048-54. [Abstract] [Full-text]
49. Maintenance immunosuppression with mycophenolate mofetil and corticosteroids in pediatric kidney transplantation: temporary benefit but not without risk.
    Transplantation, 83(8): 1041-7. [Abstract] [Full-text]
50. Evaluation of hepatocyte growth factor as a sensitive marker for early detection of acute renal allograft rejection.
    Transplantation, 83(8): 1035-40. [Abstract] [Full-text]
51. Diabetic complications associated with new-onset diabetes mellitus in renal transplant recipients.
    Transplantation, 83(8): 1027-34. [Abstract] [Full-text]
52. Renal pathology in the pediatric transplant patient.
    Adv Anat Pathol, 14(3): 202-16. [Abstract] [Full-text]
53. Intrasubject medication adherence patterns.
    Clin Nurs Res, 16(2): 153-63. [Abstract] [Full-text]
54. Malignancies in renal transplantation: an unmet medical need.
    Nephrol Dial Transplant, 22: i4-10. [Abstract] [Full-text]
55. Use of proliferation signal inhibitors in the management of post-transplant malignancies--clinical guidance.
    Nephrol Dial Transplant, 22: i36-41. [Abstract] [Full-text]
56. Post-transplant lymphoproliferative disorder--the potential of proliferation signal inhibitors.
    Nephrol Dial Transplant, 22: i27-35. [Abstract] [Full-text]
57. Use of proliferation signal inhibitors in non-melanoma skin cancer following renal transplantation.
    Nephrol Dial Transplant, 22: i23-6. [Abstract] [Full-text]
58. Kaposi's sarcoma in renal transplant recipients--the impact of proliferation signal inhibitors.
    Nephrol Dial Transplant, 22: i17-22. [Abstract] [Full-text]
59. The role of proliferation signal inhibitors in post-transplant malignancies.
    Nephrol Dial Transplant, 22: i11-6. [Abstract] [Full-text]
60. Complications after a 5-year experience with laparoscopic donor nephrectomy: the Indiana University experience.
    Surg Endosc, 21(5): 724-8. [Abstract] [Full-text]
61. Effects of deflazacort vs. methylprednisone: a randomized study in kidney transplant patients.
    Pediatr Nephrol, 22(5): 734-41. [Abstract] [Full-text]
62. Diagnosis of de novo localized thrombotic microangiopathy by surveillance biopsy.
    Pediatr Nephrol, 22(5): 742-6. [Abstract] [Full-text]
63. Post transplant development of MICA and anti-HLA antibodies is associated with acute rejection episodes and renal allograft loss.
    Hum Immunol, 68(5): 362-7. [Abstract] [Full-text]
64. Outcomes of invasive zygomycosis infections in renal transplant recipients.
    Transpl Infect Dis, 9(2): 161-4. [Abstract] [Full-text]
65. The onset of rapidly progressive neurologic deterioration after a brief gastrointestinal illness in a renal allograft recipient.
    Transpl Infect Dis, 9(2): 142-7. [Abstract] [Full-text]
66. Tuberculosis in renal transplant recipients.
    Transpl Infect Dis, 9(2): 97-101. [Abstract] [Full-text]
67. New treatments for acute humoral rejection of kidney allografts.
    Expert Opin Investig Drugs, 16(5): 625-33. [Abstract] [Full-text]
68. Perioperative outcomes of cardiac surgery in kidney and kidney-pancreas transplant recipients.
    J Thorac Cardiovasc Surg, 133(5): 1212-9. [Abstract] [Full-text]

© 2004-2008 Kidney Transplant Research Today. All Rights Reserved.